Skip to content

Aquestive Therapeutics, Inc. AQST Increase (Decrease) in Prepaid Expense and Other Assets

Increase (Decrease) in Prepaid Expense and Other Assets at other companies

ARS Pharmaceuticals, Inc. logo
ARS Pharmaceuticals, Inc.SPRY
$524K-89.1%
AMP
Amphastar PharmaceuticalsAMPH
$2.33M+174%
Avalo Therapeutics logo
Avalo TherapeuticsAVTX
-$228K+90.9%
Absci Corporation logo
Absci CorporationABSI
$862K+193%
AptarGroup logo
AptarGroupATR
AbbVie logo
AbbVieABBV

Other financials

Income statement

See full
Revenue$14.4M+65.7%
Gross profit$11.0M+117%
Operating income-$4.2M+78.3%
Net income-$8.1M+64.9%
EPS (diluted)-$0.07+70.8%

Balance sheet

See full
Cash & equivalents$110.7M+61.3%
Total debt$64.4M+7.4%
Total equity-$34.1M+44.1%
Total assets$141.1M+38.0%

Cash flow

See full
Operating cash flow-$14.8M+36.7%
CapEx$52.0K-61.5%
Free cash flow-$14.9M+36.9%

Valuation

See full
Market cap$560.13M+73.5%
Enterprise value$513.76M+63.6%
P/S11.1×+5.2×

Profitability

See full
Gross margin63.5%-4.9pp
Operating margin-111.2%+96.3pp
Net margin-137.1%+80.7pp
FCF margin-88.2%-2.2pp

Returns & leverage

See full
Return on equity145.1%
Debt / equity-1.9×
Current ratio4.1×-0.8×

Where this comes from

Reported directly by Aquestive Therapeutics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets.

The official record: Aquestive Therapeutics, Inc.’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about Aquestive Therapeutics, Inc.'s increase (decrease) in prepaid expense and other assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Aquestive Therapeutics, Inc.'s increase (decrease) in prepaid expense and other assets?
Aquestive Therapeutics, Inc. (AQST) reported increase (decrease) in prepaid expense and other assets of $340K in Q1 2026.
How has Aquestive Therapeutics, Inc.'s increase (decrease) in prepaid expense and other assets changed year-over-year?
Aquestive Therapeutics, Inc.'s increase (decrease) in prepaid expense and other assets increased by 180.4% year-over-year, from -$423K to $340K.
What does increase (decrease) in prepaid expense and other assets mean?
This tracks changes in cash paid in advance for goods or services that will be consumed in future periods. It reflects the timing difference between cash outflows and the recognition of related expenses on the income statement.